CD169+ macrophages significantly enhance T-cell proliferation, CD8+ cytotoxicity, and cytokine production in a CD169-dependent manner; further, autocrine TGF-β produced by tumor-stimulated macrophages is involved in downregulating CD169 expression [20]. This evidence concerns the gene SIGLEC1 and neoplasm.